Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment

European Neuropsychopharmacology

Volumn 16, Issue 3, 2006, Pages 187-194

  Cohen, D ^a,d   Dekker, J J ^b   Peen, J ^b   Gispen De Wied, C C ^c  

^a Psychiatric Institute Rijngeest   (Netherlands)

^b JellinekMentrum   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Division of Chronic Care   (Netherlands)

Author keywords

Diabetes mellitus type 2; Long term treatment; Neuroleptics; Schizophrenia

Indexed keywords

BUTYROPHENONE DERIVATIVE; CLOZAPINE; GLUCOSE; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIOXANTHENE DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OBESITY; SCHIZOPHRENIA;

EID: 33644843006     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.09.003     Document Type: Article

References (94)

1. D.B. Allison, J.L. Mentore, M. Heo, L.P. Chandler, J.C. Cappelleri, M.C. Infante, and P.J. Weiden Antipsychotic-induced weight gain: a comprehensive research synthesis Am. J. Psychiatry 156 1999 1686 1696
2. A. Amdisen Diabetes mellitus as a side effect of treatment with tricyclic neuroleptics Acta Psychiatr. Scand. 180 1964 411 414
3. American Diabetes Association, American Psychiatric Association, American Association of Clinical endocrinologists, and North American Association for the Study of Obesity Consensus development conference on antipsychotic drugs and obesity and diabetes Diabetes Care 27 2004 596 601
4. H.P.T. Ammon, L. Orci, and J. Steinke Effect of chlorpromazine (CPZ) on insulin release in vivo and in vitro in the rat J. Pharmacol. Exp. Ther. 187 1973 423 429
5. T. Baptista Mechanisms of weight gain induced by antipsychotic drugs J. Clin. Psychiatry 63 2002 245 246
6. T. Baptista, N.M.K.N.Y. Kin, S. Beaulieu, and E.A. de Baptista Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives Pharmacopsychiatry 35 2002 205 219
7. T. Baptista, E.A. de Baptista, J. Lalonde, J. Plamondon, N.M. Kin, S. Beaulieu, and Richard D. Joober Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection Prog. Neuro-psychopharmacol. Biol. Psychiatry 28 2004 1305 1311
8. T. Baptista, J. Zarate, R. Joober, S. Beaulieu, C.O. Colasanto, X. Páez, and L. Hernández Drug-induced weight-gain: an impediment for successful pharmacotherapy: focus on antipsychotics Curr. Drug Targets 5 2004 279 299
9. V.S. Basile, M. Masellis, R.S. McIntyre, H.Y. Meltzer, J.A. Lieberman, and J.L. Kennedy Genetic dissection of atypical antipsychotic-induced weight gain: a novel preliminary data on the pharmacogenetic puzzle J. Clin. Psychiatry 62 Suppl 23 2001 45 66
10. L. Berghout, K. Gorter, and G. Rutten Verbetering van glykemische regulering zonder exogeen insuline bij 40% van de slecht ingestelde patiënten met diabetes mellitus type 2; een onderzoek in 18 huisartspraktijken Ned. Tijdschr. Geneeskd. 145 2001 2035 2039
11. T.L. Bettinger, S.C. Mendelson, P.G. Dorson, and M.L. Crismon Olanzapine-induced glucose dysregulation Ann. Pharmacother. 34 2000 865 867
12. M.B. Bhide, N.M. Tiwari, and J.H. Balwani Effect of chlorpromazine on peripheral utilisation of glucose Arch. Int. Pharmacodyn. Ther. 156 1965 166 171
13. A. Bonaccorsi, S. Garattini, and A. Jori Studies on the hyperglycaemia induced by chlorpromazine in rats Br. J. Pharmacol. 23 1964 93 100
14. F.J. Braceland, L.J. Meduna, and J.A. Vaichulis Delayed action of insulin in schizophrenia Am. J. Psychiatry 102 1945 108 110
15. N.J. Brugman, D. Cohen, and R.H. de Vries Diabetes mellitus ontstaan na behandeling met clozapine Ned. Tijdschr. Geneeskd. 144 2000 437 439
16. J.B. Buse, P. Cavazzoni, K. Hornbuckle, D. Hutchins, A.S. Brier, and L. Jovanovic A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States J. Clin. Epidemiol. 56 2003 164 170
17. F.B.E. Charatan, and N.G. Bartlett The effect of chlorpromazine ("Largactil") on glucose tolerance J. Ment. Sci. 101 1955 351 353
18. J.R. Clayer, and M.N. Dumbrill Diabetes mellitus and mental illness Med. J. Aust. I 1967 901 904
19. D. Cohen Atypical antipsychotics and new onset diabetes mellitus Pharmacopsychiatry 36 2004 1 11
20. D. Cohen Diabetes mellitus during olanzapine and quetiapine treatment in Japan J. Clin. Psychiatry 66 2005 265 266
21. D. Cohen, B. Puite, J.J. Dekker, and C.C. Gispen-de Wied Diabetes mellitus in 93 chronic schizophrenic inpatients Eur. J. Psychiatry 17 2003 38 47
22. A. Colli, M. Cocciolo, G. Francobandiera, F. Rogantin, and N. Cattalini Diabetic ketoacidosis associated with clozapine treatment Diabetes Care 22 1999 176 177
23. P.E. Croarkin, K.M. Jacobs, and B.K. Bain Diabetic ketoacidosis associated with risperidone treatment? Psychosomatics 41 2000 369 370
24. A.T. Dawn, T.A. Roper, and J.A. Riley Diabetic ketoacidosis and clozapine Adverse Drug React. 1997 493 494
25. J. Delay, P. Deniker, H. Grasset, and A. Grasset Traitements d'états confusionnels par le chlorhydrate de diéthylaminopropyl-N- chlorophénothiazine (4560 RP) Ann. Med. Psychol. 110 1952 398 403
26. L. Dixon, P. Weiden, J. Delahanty, R. Goldberg, L. Postrado, A. Lucksted, and A. Lehman Prevalence and correlates of diabetes in national schizophrenia samples Schizophr. Bull. 26 2001 903 912
27. S.E. Domon, and C.S. Cargile Quetiapine-associated hyperglycemia and hypertriglyceridemia J. Am. Acad. Child Adolesc. Psych. 41 2002 495 496
28. D.S. Dwyer Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC 12 cells Progr. Neuro-Psychopharmacol. Biol. Psychiatry 23 1999 69 80
29. D.S. Dwyer, and D. Donohoe Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake Pharmacol. Biochem. Behav. 75 2003 255 260
30. D.S. Dwyer, R.J. Bradley, A.S. Kablinger, and A.M. Freeman Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment Ann. Clin. Psychiatry 13 2001 103 113
31. M.K. Fertig, V.G. Brooks, and P.S. Shelton Hyperglycemia associated with olanzapine J. Clin. Psychiatry 59 1998 687 689
32. G.O.H. Finney Juvenile onset diabetes and schizophrenia? Lancet 1989 1214 1215
33. H. Freeman Resistance to insulin in mentally disturbed soldiers Arch. Neurol. Psychiatry 56 1946 74 78
34. T. Ghafghazi, T.S. Miya, J.H. Mennear, and R.K. Chalmers Chlorpromazine and epinephrine hyperglycemic mechanisms J. Pharm. Sci. 57 1968 1690 1693
35. F.D. Gianfrancesco, A.L. Grogg, R.A. Mahmoud, R.-h. Wang, and H.A. Nasrallah Differential effects of risperidone, olanzapine, clozapine and conventional antipsychotics on type 2 diabetes: findings from a large health plan database J. Clin. Psychiatry 63 2002 920 930
36. F. Gianfrancesco, R. White, R.-h. Wang, and H.A. Nasrallah Antipsychotic-induced type 2 diabetes: evidence from a large health plan database J. Clin. Psychopharmacol. 23 2003 328 335
37. L.E. Goldstein, J. Sporn, S. Brown, H. Kim, J. Finkelstein, G.K. Gaffey, G. Sachs, and T.A. Stern New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment Psychosomatics 40 1999 438 443
38. A.K. Gopalaswamy, and R. Morgan Too may chronic mentally disabled patients are too fat Acta Psychiatr. Scand. 72 1985 254 258
39. D. Gothelf, B. Falk, P. Singer, M. Kairi, M. Phillip, L. Zigel, I. Poraz, S. Frishman, N. Constantini, A. Weizman, and A. Apter Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine Am. J. Psychiatry 159 2002 1055 1057
40. S.K. Gupta, M.A. Patel, and A.D. Joseph Effects of chlorpromazine and epinephrine on blood-sugar of rabbits Arch. Int. Pharmacodyn. 127 1960 82 88
41. S. Hägg, L. Joelsson, T. Mjörndal, O. Spigset, G. Oja, and Dahlqvist Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications J. Clin. Psychiatry 59 1998 294 299
42. D.C. Henderson, E. Cagliero, C. Gray, R.A. Nasrallah, D.L. Hayden, D.A. Schoenfeld, and D.C. Goff Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study Am. J. Psychiatry 157 2000 975 981
43. K. Hermansen Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagons and insulin release from the isolated, perfused canine pancreas Diabetologia 15 1978 343 347
44. B.W. Hiles Hyperglycemia and glycosuria following chlorpromazine therapy JAMA 162 1956 1651
45. H.G. Joost, B. Göke, and A. Hasselblatt Effects of pimozide and apomorphine on insulin secretion from the perfused rat pancreas Arch. Int. Pharmacodyn. 263 1983 155 163
46. A. Jori, and M.C. Carrara On the mechanism of hyperglycaemic effect of chlorpromazine J. Pharm. Pharmacol. 18 1966 623 624
47. A. Kamran, P.M. Doraiswamy, J.L. Jane, E.B. Hammett, and L. Dunn Severe hyperglycemia associated with high doses of clozapine Am. J. Psychiatry 151 1994 1395
48. A. Keskiner, A. el Toumi, and T. Bousquet Psychotropic drugs, diabetes and chronic mental illness Psychosomatics 14 1973 176 181
49. E.A. Koller, and P.M. Doraiswamy Olanzapine-associated diabetes mellitus Pharmacotherapy 22 2002 841 852
50. E.A. Koller, B. Schneider, K. Bennett, and G. Dubitsky Clozapine-associated diabetes Am. J. Med. 111 2001 716 723
51. E.A. Koller, J.T. Cross, P.M. Doraiswamy, and B.S. Schneider Risperidone-associated diabetes mellitus: a pharmacovigilance study Pharmacotherapy 23 2003 735 744
52. E.A. Koller, J. Weber, P.M. Doraiswamy, and B.S. Schneider A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus J. Clin. Psychiatry 65 2004 857 863
53. F.H. Kooy Hyperglycaemia in mental disorders Brain 42 1919 215 289
54. C.J. Kornegay, C. Vasilakis-Scaramozza, and H. Jick Incident diabetes associated with antipsychotic use in the United Kingdom General Practice Research Database J. Clin. Psychiatry 63 2002 758 762
55. C.E. Koro, D.O. Fedder, G.J. L'Italien, S.S. Weiss, L.S. Magder, J. Kreyenbuhl, D.A. Revicki, and R.W. Buchanan Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study BMJ 325 2002 243 247
56. W.K. Kroeze, S.J. Hufeisen, B.A. Popadak, S.M. Renock, S. Steinberg, P. Ernsberger, K. Jayathilake, H.Y. Meltzer, and B.L. Roth HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs Neuropsychopharmacology 28 2003 519 526
57. M.E.J. Lean, and F.-G. Pajonk Patients on atypical antipsychotic drugs Diabetes Care 26 2003 1597 1605
58. K.A. Liebzeit, J.S. Markowitz, and C.F. Caley New onset diabetes and atypical antipsychotics Eur. Neuropharmacol. 11 2001 25 32
59. J.-P. Lindenmayer, and R. Patel Olanzapine-induced ketoacidosis with diabetes mellitus Am. J. Psychiatry 156 1999 1471
60. J.P. Lindenmayer, P. Czobor, J. Volavka, L. Citrome, B. Sheitman, J.P. McEvoy, T.B. Cooper, M. Chakos, and J.A. Lieberman Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics Am. J. Psychiatry 166 2003 290 296
61. B.C. Lund, P.J. Perry, J.M. Brooks, and S. Arndt Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension Arch. Gen. Psychiatry 58 2001 1171 1176
62. K. Melkersson Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro Eur. Neuropsychopharmacol. 14 2005 115 119
63. K.I. Melkersson, A.-L. Hultin, and K.E. Brismar Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia and related psychoses J. Clin. Psychiatry 60 1999 783 791
64. K.I. Melkersson, A-L. Hulting, and K.E. Brismar Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses J. Clin. Psychiatry 61 2000 742 749
65. K.I. Melkersson, A. Khan, A. Hilding, and A.-L. Hulting Different effects of antipsychotic drugs on insulin release in vitro Eur. Neuropsychopharmacol. 11 2001 327 332
66. J.M. Meyer, S.G. Lekband, C.C. Loh, and C.Y. Moutier Quetiapine-induced diabetes with metabolic acidosis Int. Clin. Psychopharmacol. 19 2004 169 171
67. F. Misawa, S. Miyayi, Y. Fujii, R. Miyata, K. Obi, F. Koshiishi, H. Shimada, M. Fukuda, and T. Koizumi The incidence of hyperglycemia in patients treated with olanzapine J. Clin. Psychiatry 65 2004 443 444
68. D. Mohan, H. Gordon, N. Hindley, and A. Barker Schizophrenia and diabetes mellitus Br. J. Psychiatr. 174 1999 180 181
69. Mooy, J.M., 1995. Non-insulin-dependent diabetes mellitus in a general Caucasian population. Thesis. Amsterdam 1995, p.46.
70. S. Mukherjee, D.B. Schnur, and R. Reddy Family history of type 2 diabetes in schizophrenic patients Lancet 1 1989 495
71. S. Mukherjee, P. Decina, V. Bocola, F. Saraceni, and P.L. Scapicchio Diabetes mellitus in schizophrenic patients Compr. Psychiatry 37 1996 68 73
72. NHG-standaard Diabetes Mellitus type 2 Huisarts Wet. 42 1999 67 74
73. R.M. Procyshyn, S. Pande, and G. Tse New-onset diabetes mellitus associated with quetiapine Can. J. Psychiatry 45 2000 668 669
74. W.T. Regenold, R.K. Thapar, C. Marano, S. Gavirneni, and P.V. Kondapavuluru Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use J. Affect. Disord. 70 2002 19 26
75. G.P. Reynolds, Z.J. Zhang, and X.B. Zhang Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism Lancet 359 2002 2086 2087
76. G.P. Reynolds, Z. Zhang, and X. Zhang Polymorhism of the promoter region of the serotonin 5-HT2c receptor gene and clozapine-induced weight gain Am. J. Psychiatry 160 2003 677 679
77. L. Schwarz, and R. Munoz Blood sugar levels in patients treated with chlorpromazine Am. J. Psychiatry 125 1968 253 255
78. M.J. Sernyak, D.L. Leslie, R.D. Alarcon, M.F. Losonzcy, and R. Rosenheck Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia Am. J. Psychiatry 159 2002 561 566
79. T. Silverstone, G. Smith, and E. Goodall Prevalence of obesity in patients receiving depot antipsychotics Br. J. Psychiatry 153 1988 214 217
80. M. Sobel, E.D. Jaggers, and M.A. Franz New-onset diabetes mellitus associated with the initiation of quetiapine J. Clin. Psychiatry 60 1999 556 557
81. J.M. Stanton Weight gain associated with neuroleptic medication: a review Schizophr. Bull. 21 1995 463 472
82. D.M. Taylor, and R. McAskill Atypical antipsychotics and weight gain-a systematic review Acta Psychiatr. Scand. 101 2000 416 432
83. E. Thonnard-Neumann Phenothiazines and diabetes in hospitalized women Am. J. Psychiatry 124 1968 138 142
84. M. Virkkunen, K. Wahlbeck, A. Rissanen, H. Naukkarinen, and A. Franssila-Kallunki Decrease of energy expenditure causes weight increase in olanzapine treatment - a case study Pharmacopsychiatry 35 2002 124 126
85. L. Waitzkin A survey for unknown diabetics in a mental hospital: 1. Men under age fifty Diabetes 15 1966 97 104
86. L. Waitzkin A survey for unknown diabetics in a mental hospital: 2. Men from age fifty Diabetes 15 1966 164 172
87. P.S. Wang, R.J. Glynn, D.A. Ganz, S. Schneeweiss, R. Levin, and J. Avorn Clozapine use and risk of diabetes mellitus J. Clin. Psychopharmacol. 22 2002 236 243
88. H. Wehring, B. Alexander, and P.J. Perry Diabetes mellitus associated with clozapine therapy Pharmacotherapy 20 2000 844 847
89. H. Wehring, D.L. Kelly, R.C. Love, and R.R. Conley Deaths from diabetic ketoacidosis after long-term clozapine treatment Am. J. Psychiatry 160 2003 2241 2242
90. T. Wetterling Bodyweight gain with atypical neuroleptics. A comparative review Drug Safety 24 2001 59 73
91. WHO Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complication: Part 1. Diagnosis and Classification of Diagnosis Mellitus 1999 WHO Geneva
92. D.R. Wilson, L. D'Souza, N. Sarkar, M. Newton, and C. Hammond New-onset diabetes and ketoacidosis with atypical antipsychotics Schizophr. Res. 59 2002 1 6
93. D.A. Wirshing, B.J. Spellberg, S.M. Erhart, S.R. Marder, and W.C. Wirshing Novel antipsychotics and new onset diabetes Biol. Psychiatry 44 1998 778 783
94. D.A. Wirshing, W.C. Wirshing, L. Kysar, M.A. Berisford, D. Goldstein, J. Pashdag, J. Mintz, and S.R. Marder Novel antipsychotics: comparison of weight gain liabilities J. Clin. Psychiatry 60 1999 358 363